Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Inovio initiates dosing in Phase II segment of Covid-19 therapy trial

pharmaceutical-technologyDecember 09, 2020

Tag: INO-4800 , INOVIO , COVID-19 , Innovate

PharmaSources Customer Service